Current status of medical biotechnology in Malaysia.

Journal: PubMed • • National Institutes of Health

Abstract

In recent years medical research, utilising biotechnology and related tools, has contributed significantly to advances in the laboratory diagnosis of infectious diseases and hormonal disorders in Malaysia, The main thrust was in the development of diagnostic assays or kits, either for import substitution or to meet diagnostic needs for diseases of importance, Emphasis was on the development of diagnostic probes either using the hybridoma technology for the production of monoclonal antibodies (MABs) or the development of nucleic acid probes, In other instances, more conventional techniques for the production of polyclonal antibodies and their subsequent radiolabelling for radioimmunoassays were carried out The applicability of polymerase chain reaction (peR) in the development of rapid and specific diagnostic assays was investigated, Examples of research utilising conventional as well as newer techniques were those in viral diseases like dengue, dengue haemonhagic fever, Japanese B encephalitis, and Hepatitis B virus, A mosquito larva inoculation method was developed and refined for the rapid isolation (4 days) of dengue virus 1,2, An IgM capture ELISA using monoclonal antibodies was found to be useful for the early diagnosis of dengue infection3, A similar test using cell culture derived dengue antigens and a polyclonal rabbit antiflavivirus antisera, and a dot enzyme immunoassay for the detection of dengue were also developed4, The former

Subjects & Keywords

How to Cite this Article

Joon Wah Mak, B A Khalid (1992). "Current status of medical biotechnology in Malaysia.". PubMed.